UAE residents always welcome the onset of cool winter months, but there are some who suffer from seasonal ailments like ...

Feeling stuffy and ready to reach for NyQuil, Benadryl, or Sudafed PE? Not so fast. The Food and Drug Administration has ...

Since Permatan doesn’t rely on the same controversial active ingredient as nasal sprays, it is considered to be safer in ...

ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS Pharmaceuticals, Inc. (“ARS Pharma”, NASDAQ: SPRY). The agreement grants ALK ...

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...

ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions: Hørsholm, Denmark Tuesday, November 12, 2024, 12:00 Hrs [IST] ...

Allergies affect an extensive number of individuals globally and their symptoms vary from mild to severe, which might manifest as sneezing, a runny nose, and itchy eyes. One of the most potent ...

Yes. Just ask Marianne McCall. A few allergy seasons back, she thought her seasonal congestion might never end. In April, she’d begun to use a topical nasal-spray decongestant. The over-the ...

Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...

Medically reviewed by Daniel More, MD You can stop allergies with a variety of natural remedies, including breathing in steam ...

ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak ...